NCT07855354 Safety and Efficacy of Papillary Versus NonPapillary Access During Percutaneous Nephrolithotomy
| NCT ID | NCT07855354 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Safety |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-11-01 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate and compare the safety, efficacy, and clinical outcomes of papillary and non-papillary renal access during percutaneous nephrolithotomy (PCNL), and to determine whether non-papillary puncture can be considered a safe and effective alternative to the conventional papillary approach in selected patients.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Solitary or multiple renal calculi ≥2 cm * Ability to provide informed consent Exclusion Criteria: * Bleeding diathesis or uncorrected coagulopathy * Active urinary tract infection at the time of surgery * Congenital anomalies severely distorting renal anatomy (e.g., horseshoe kidney, ectopic kidney) * Morbid obesity \[body mass index (BMI) ≥ 40\] limiting safe positioning * Pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07855354 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Safety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07855354 currently recruiting?
Yes, NCT07855354 is actively recruiting participants. Contact the research team at 29709041800133@med.asu.edu.eg for enrollment information.
Where is the NCT07855354 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07855354 clinical trial?
NCT07855354 is sponsored by Ain Shams University. The trial plans to enroll 70 participants.